Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2021-12-13 | New | $900,000 | $900,000 | Debt Only | 06b | SEC link |
| 2020-12-17 | New | $3,194,000 | $3,194,000 | Debt Only | 06b | SEC link |
| 2019-09-09 | Amended | $4,308,791 | $0 | Equity Only | 06b | SEC link |
| 2019-09-06 | New | $4,308,791 | $4,308,791 | Equity Only | 06b | SEC link |
| 2018-09-11 | New | $4,499,744 | $4,499,744 | Equity Only | 06b | SEC link |
| 2016-09-01 | New | $356,249 | $356,249 | Equity Only | 06b | SEC link |
| 2010-07-02 | New | $1,100,064 | $1,100,064 | Equity Only | 06 | SEC link |
| Name | Role |
|---|---|
| Thomas A. Afzal | Director, Executive |
| Ted Bird | Director |
| Cheryl Blanchard | Director |
| David Gill | Director |
| Donald Grimm | Director |
| Huntbrew Partnership Huntbrew Partnership | Promoter |
| Richard Intrater | Director |
| Gary Jacobs | Director |
| Douglas Kohrs | Director |
| Debora La Budde | Director |
| Robert Lachenauer | Director, Executive |
| Arpesh Mehta | Director |
| Paul Nichols | Director |
| Paul K. Nichols, Jr. | Director, Executive |
| Arthur O'dea | Executive |
| Art O/Dea | Executive |
| Adam Wallen | Director, Executive |
| Pieter Wolters | Director |